Trial Profile
Glatiramer acetate's effect on spinal cord volume in patients with relapsing-remitting multiple sclerosis: A pilot study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jul 2017
Price :
$35
*
At a glance
- Drugs Glatiramer acetate (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 08 Jul 2017 New trial record